Trial NCT04355728
Publication Lanzoni G, Stem Cells Transl Me, 2020
Primary outcome on the report: Safety, as defined by the occurrence of pre-specified infusion associated AEs, occurring within 6 hours from each infusion; Cardiac arrest or death within 24 h post infusion; Incidence of AEs